However, the selective inhibition of MAGL (JZL184) and dual inhibition of FAAH and MAGL (JZL195) alleviated both the inflammatory response and AHR, suggesting a promising therapeutic strategy for allergic asthma [59]. This evidence concerns the gene AHR and allergic asthma.